ZA200201250B - Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11. - Google Patents

Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.

Info

Publication number
ZA200201250B
ZA200201250B ZA200201250A ZA200201250A ZA200201250B ZA 200201250 B ZA200201250 B ZA 200201250B ZA 200201250 A ZA200201250 A ZA 200201250A ZA 200201250 A ZA200201250 A ZA 200201250A ZA 200201250 B ZA200201250 B ZA 200201250B
Authority
ZA
South Africa
Prior art keywords
alkyl
alkynyl
alkenyl
alpha
hydrocarbon substituent
Prior art date
Application number
ZA200201250A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Wilhelmus Gerardus Ed Schoonen
Gerrit Herman Veeneman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200201250B publication Critical patent/ZA200201250B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200201250A 1999-09-06 2002-02-13 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11. ZA200201250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06

Publications (1)

Publication Number Publication Date
ZA200201250B true ZA200201250B (en) 2003-07-30

Family

ID=8240610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201250A ZA200201250B (en) 1999-09-06 2002-02-13 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.

Country Status (24)

Country Link
US (1) US6677329B1 (xx)
EP (1) EP1224204B1 (xx)
JP (1) JP2003508541A (xx)
KR (1) KR20020092907A (xx)
CN (2) CN1185249C (xx)
AT (1) ATE295851T1 (xx)
AU (1) AU770331B2 (xx)
BR (1) BR0013769A (xx)
CA (1) CA2382489C (xx)
CZ (1) CZ2002831A3 (xx)
DE (1) DE60020260T2 (xx)
EC (1) ECSP013947A (xx)
ES (1) ES2241657T3 (xx)
HU (1) HUP0202595A3 (xx)
IL (2) IL148116A0 (xx)
MX (1) MXPA02001831A (xx)
NO (1) NO20021079L (xx)
NZ (1) NZ517281A (xx)
PL (1) PL353826A1 (xx)
RU (1) RU2245886C2 (xx)
SK (1) SK3282002A3 (xx)
TR (1) TR200200575T2 (xx)
WO (1) WO2001018027A1 (xx)
ZA (1) ZA200201250B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
US6677329B1 (en) * 1999-09-06 2004-01-13 Akzo Nobel N V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
US7041839B2 (en) * 2000-06-22 2006-05-09 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
SK882003A3 (en) * 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
ES2881336T3 (es) * 2016-03-03 2021-11-29 Crystal Pharma Sau Procedimiento y nuevos productos intermedios para la preparación de 11-metilen-esteroides
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1112840A (en) 1964-04-07 1968-05-08 Res Inst Medicine Chem Steroids having pro-oestrogenic activity
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
AU671706B2 (en) * 1993-03-05 1996-09-05 Akzo N.V. Use of a Pregnane Derivative
WO1999045886A2 (en) 1998-03-09 1999-09-16 Akzo Nobel N.V. New contraceptive kit for monotherapy
US6677329B1 (en) * 1999-09-06 2004-01-13 Akzo Nobel N V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Also Published As

Publication number Publication date
CN1372565A (zh) 2002-10-02
PL353826A1 (en) 2003-12-01
ES2241657T3 (es) 2005-11-01
IL148116A0 (en) 2002-09-12
RU2245886C2 (ru) 2005-02-10
DE60020260D1 (de) 2005-06-23
EP1224204A1 (en) 2002-07-24
CN1637016A (zh) 2005-07-13
MXPA02001831A (es) 2002-10-23
CN100354299C (zh) 2007-12-12
BR0013769A (pt) 2002-04-30
CA2382489C (en) 2008-03-11
US6677329B1 (en) 2004-01-13
AU7511700A (en) 2001-04-10
DE60020260T2 (de) 2006-01-19
CN1185249C (zh) 2005-01-19
NZ517281A (en) 2003-09-26
NO20021079L (no) 2002-04-29
HUP0202595A3 (en) 2004-06-28
ECSP013947A (es) 2002-09-27
JP2003508541A (ja) 2003-03-04
NO20021079D0 (no) 2002-03-05
IL148116A (en) 2006-10-31
CZ2002831A3 (cs) 2002-05-15
CA2382489A1 (en) 2001-03-15
KR20020092907A (ko) 2002-12-12
AU770331B2 (en) 2004-02-19
WO2001018027A1 (en) 2001-03-15
ATE295851T1 (de) 2005-06-15
EP1224204B1 (en) 2005-05-18
TR200200575T2 (tr) 2002-06-21
HUP0202595A2 (hu) 2002-12-28
SK3282002A3 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
IL148116A0 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
WO1996040043A3 (en) Neuroactive steroids of the androstane and pregnane series
DK0633893T3 (da) 17-Substituerede steroider, der er nyttige ved cancerbehandling
AU665430B2 (en) 17-spiromethylene steroids
EP1310509A3 (en) Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
RS20070075A (xx) 15beta-supstituisani steroidi sa selektivnom estrogenskom aktivnošću
KR930017917A (ko) 스테로이드 유도체
NZ512923A (en) Potent sulfatase inhibitors that are metabolically stable, selective and devoid of estrogenic activity
RU2002108723A (ru) Неароматические эстрогенные стероиды с углеводородным заместителем в положении 11
ZA805249B (en) New amino-14 steriod derivatives and process for preparataion of the same
NO931951D0 (no) 2beta,19-metylenaminobroede steroider som aromataseinhibitorer
CA2260584A1 (en) Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
PT1196428E (pt) Esteroides substituidos com 11 beta-aril-17, 17-espirotiolano
MXPA03005224A (es) Esteroides de metileno como androgenos novedosos.
CO5251432A1 (es) Derivados de 3-metileno esteroides
CO5261633A1 (es) Compuestos estrogenicos